Company profile
Nucleix company profile
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
Business identity
- Website
- http://nucleix.com
- Contact email
- [email protected]
- Phone number
- +97289161616
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2008-01-01, Year
Headquarters
- Headquarters
- Reẖovot, Central District, Israel
- Postal code
- 7670203
- Country code
- IL
- Continent
- Asia